The modifying effects of adiposity on the cardiovascular safety of sulphonylureas.
Seoyoung C KimSebastian SchneeweissAntonios DourosKristian B FilionHui YinElisabetta PatornoLaurent AzoulayPublished in: Diabetes, obesity & metabolism (2021)
The findings of this study suggest that adiposity may have a modifying effect on the association between sulphonylureas and cardiovascular and all-cause mortality compared with metformin.